Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia
- Daniela Sepúlveda-Beltran,
- Alvaro Mondragón-Cardona,
- Carlos Enrique Conde-Martin,
- Oscar Alberto Lopez-Guevara,
- Nubia Rocio Hernandez-Rojas,
- Mario Alberto Caviedes-Cleves
- Sociedad Clínica Emcosalud,
- Universidad Surcolombiana,
- Latin American Network of COVID-19 Research (LANCOVID),
- Fundacion Universitaria Autonoma de las Américas,
- ICAR-Indian Veterinary Research Institute
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 131-137 (7 pages)Journal (Volume, Issue Number)
Journal of Experimental Biology and Agricultural Sciences (Volume 9, Issue 2)Publication milestones
- Published - 2021
Publication status
Publication IDs
- Scopus: 85114329586
Abstract
Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection.